Opexa Therapeutics, Inc.·4

May 18, 6:32 PM ET

Opexa Therapeutics, Inc. 4

4 · Opexa Therapeutics, Inc. · Filed May 18, 2016

Insider Transaction Report

Form 4
Period: 2016-05-16
Rill Donna R
Senior V.P. of Operations
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2016-05-16+50,00050,000 total
    Exercise: $2.13Exp: 2026-05-16Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]25% vests on the date of grant and the remaining 75% vests quarterly over the ensuing three years.

Documents

1 file
  • 4
    issuerdirect_section16.xmlPrimary

    PRIMARY DOCUMENT